NEW YORK (GenomeWeb News) – GE Healthcare today reported that fourth-quarter revenues for its GE Healthcare business, which includes the firm's tools for molecular research, declined 3 percent year over year.

GE Healthcare's revenues were $4.8 billion for the quarter compared to $5 billion in Q4 of 2007. The unit's profit dropped 9 percent to $942 million from $1 billion year over year.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

American scientists find themselves once again warning the Trump administration not to dismiss science, the New Yorker report.

A new study suggests CRISPR could be used to save coral reefs from dying off, Forbes reports.

Researchers have found that the i-motif shape of DNA previously observed in the lab also exists in human cells, and that it may serve a purpose.

In PNAS this week: a genomic, transcriptomic, and metabolomic analysis of the tea plant, Arabidopsis thaliana's adaptations to specific local environments, and more.